Kemeny N - Search Results

1

Immunization of colorectal cancer patients with modified ovine submaxillary gland mucin and adjuvants induces IgM and IgG antibodies to sialylated Tn.

O'Boyle KP, Zamore R, Adluri S, Cohen A, Kemeny N, Welt S, Lloyd KO, Oettgen HF, Old LJ, Livingston PO. O'Boyle KP, et al. Among authors: kemeny n. Cancer Res. 1992 Oct 15;52(20):5663-7. Cancer Res. 1992. PMID: 1394190

2

A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer.

Kemeny N, Seiter K, Niedzwiecki D, Chapman D, Sigurdson E, Cohen A, Botet J, Oderman P, Murray P. Kemeny N, et al. Cancer. 1992 Jan 15;69(2):327-34. doi: 10.1002/1097-0142(19920115)69:2<327::aid-cncr2820690209>3.0.co;2-u. Cancer. 1992. PMID: 1303612 Clinical Trial.

3

Type Ia glycogenosis associated with hepatocellular carcinoma.

Conti JA, Kemeny N. Conti JA, et al. Among authors: kemeny n. Cancer. 1992 Mar 15;69(6):1320-2. doi: 10.1002/1097-0142(19920315)69:6<1320::aid-cncr2820690603>3.0.co;2-d. Cancer. 1992. PMID: 1311620 Review.

4

Pseudomyxoma peritonei of appendiceal origin. The Memorial Sloan-Kettering Cancer Center experience.

Smith JW, Kemeny N, Caldwell C, Banner P, Sigurdson E, Huvos A. Smith JW, et al. Among authors: kemeny n. Cancer. 1992 Jul 15;70(2):396-401. doi: 10.1002/1097-0142(19920715)70:2<396::aid-cncr2820700205>3.0.co;2-a. Cancer. 1992. PMID: 1319813

5

Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump.

Atiq OT, Kemeny N, Niedzwiecki D, Botet J. Atiq OT, et al. Among authors: kemeny n. Cancer. 1992 Feb 15;69(4):920-4. doi: 10.1002/1097-0142(19920215)69:4<920::aid-cncr2820690414>3.0.co;2-y. Cancer. 1992. PMID: 1370918

6

Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach.

Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, Reichman B, Saltz L, Sigurdson ER, Frankel J. Minsky BD, et al. Among authors: kemeny n. J Clin Oncol. 1992 Aug;10(8):1218-24. doi: 10.1200/JCO.1992.10.8.1218. J Clin Oncol. 1992. PMID: 1634912 Clinical Trial.

7

Phase I trial of postoperative 5-FU, radiation therapy, and high dose leucovorin for resectable rectal cancer.

Minsky BD, Cohen AM, Enker WE, Kelsen DP, Kemeny N, Riechman B, Saltz L, Sigurdson ER, Frankel J. Minsky BD, et al. Among authors: kemeny n. Int J Radiat Oncol Biol Phys. 1992;22(1):139-45. doi: 10.1016/0360-3016(92)90993-r. Int J Radiat Oncol Biol Phys. 1992. PMID: 1727111 Clinical Trial.

8

Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy.

Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, Reichman B, Saltz L, Sigurdson ER, Frankel J. Minsky BD, et al. Among authors: kemeny n. J Clin Oncol. 1992 Jan;10(1):79-84. doi: 10.1200/JCO.1992.10.1.79. J Clin Oncol. 1992. PMID: 1727928

9

Therapy for colorectal cancer.

Kemeny N, Seiter K. Kemeny N, et al. Curr Opin Oncol. 1991 Aug;3(4):745-52. Curr Opin Oncol. 1991. PMID: 1932233 Review.

10

Adjuvant postoperative radiation therapy for resectable rectal cancer.

Minsky BD, Cohen AM, Enker WE, Kelsen D, Kemeny N, Sigurdson E. Minsky BD, et al. Among authors: kemeny n. Radiat Med. 1991 Jul-Aug;9(4):153-8. Radiat Med. 1991. PMID: 1961941

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

395 results

Search Page

Filters